Lo Muzio Lorenzo, Campisi Giuseppina, Farina Antonio, Rubini Corrado, Pastore Luca, Giannone Nicola, Colella Giuseppe, Leonardi Rosalia, Carinci Francesco
University of Foggia, Foggia, Italy.
Cancer Invest. 2007 Sep;25(6):464-9. doi: 10.1080/07357900701509387.
P63 is the protein codified by p63 gene, a p53 gene homolog, known for its pivotal role in cell cycle regulation, and involved in the tumor differentiation. Aims of the present study were to assess the frequency and pattern of p63 protein expression in oral squamous cell carcinoma (OSCC) in relation to the main tumour characteristics and to verify whether p63 can be considered a marker of prognosis in patients with OSCC.
In a retrospective study, a cohort of 64 OSCC patients was investigated for p63 protein expression and its cellular localization by immunohistochemistry (monoclonal mouse anti-human p63 protein-clone 4A4). After grouping by p63 expression, OSCCs were statistically analyzed for the variables age, gender, histological grading (G), TNM, staging, recurrence, and overall survival rate.
The overall frequency of p63 overexpressed was of 57.8 percent. Various p63 staining patterns were observed according to G score, with a significant correlation between p63 overexpression and the lowest G score (P < 0.0001). No statistically significant difference was found between p63 pattern expression and age, sex, staging. OSCC patients with p63 overexpressed were found to have a poorer survival rate with respect to OSCCs with a normal pattern of expression (P = 0.024).
On the basis of these results, it is possible to suggest p63 pattern expression as a reliable indicator of histological grading and an early marker of poor prognosis.
p63是由p63基因编码的蛋白质,p63基因是p53基因的同源基因,以其在细胞周期调控中的关键作用而闻名,并参与肿瘤分化。本研究的目的是评估口腔鳞状细胞癌(OSCC)中p63蛋白表达的频率和模式与主要肿瘤特征的关系,并验证p63是否可被视为OSCC患者预后的标志物。
在一项回顾性研究中,通过免疫组织化学(单克隆小鼠抗人p63蛋白克隆4A4)对64例OSCC患者队列进行p63蛋白表达及其细胞定位的研究。按p63表达分组后,对OSCC患者的年龄、性别、组织学分级(G)、TNM分期、复发情况和总生存率等变量进行统计学分析。
p63过表达的总体频率为57.8%。根据G评分观察到各种p63染色模式,p63过表达与最低G评分之间存在显著相关性(P < 0.0001)。在p63模式表达与年龄、性别、分期之间未发现统计学上的显著差异。与表达模式正常的OSCC患者相比,p63过表达的OSCC患者生存率较差(P = 0.024)。
基于这些结果,可以认为p63模式表达是组织学分级的可靠指标和预后不良的早期标志物。